D. Capaldi, K. Ackley, D. Brooks, J. Carmody, K. Draper, R. Kambhampati, M. Kretschmer, Daren S Levin, J. Mcardle, B. Noll, R. Raghavachari, I. Roymoulik, B. P. Sharma, René Thürmer, F. Wincott
{"title":"寡核苷酸药物开发的质量方面:活性药物成分的规范","authors":"D. Capaldi, K. Ackley, D. Brooks, J. Carmody, K. Draper, R. Kambhampati, M. Kretschmer, Daren S Levin, J. Mcardle, B. Noll, R. Raghavachari, I. Roymoulik, B. P. Sharma, René Thürmer, F. Wincott","doi":"10.1177/0092861512445311","DOIUrl":null,"url":null,"abstract":"This article, which is the first in a planned series intended to address chemistry, manufacturing, and control (CMC) aspects of therapeutic oligonucleotides, examines the topic of specifications for active pharmaceutical ingredients (APIs). The authors attempt to present basic scientific considerations for the broadest range of oligonucleotide APIs. Tests and analytical methods suitable for the control of single- and double-stranded oligonucleotide APIs and conjugated oligonucleotide APIs are discussed.","PeriodicalId":391574,"journal":{"name":"Drug information journal : DIJ / Drug Information Association","volume":"60 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2012-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"24","resultStr":"{\"title\":\"Quality Aspects of Oligonucleotide Drug Development: Specifications for Active Pharmaceutical Ingredients\",\"authors\":\"D. Capaldi, K. Ackley, D. Brooks, J. Carmody, K. Draper, R. Kambhampati, M. Kretschmer, Daren S Levin, J. Mcardle, B. Noll, R. Raghavachari, I. Roymoulik, B. P. Sharma, René Thürmer, F. Wincott\",\"doi\":\"10.1177/0092861512445311\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This article, which is the first in a planned series intended to address chemistry, manufacturing, and control (CMC) aspects of therapeutic oligonucleotides, examines the topic of specifications for active pharmaceutical ingredients (APIs). The authors attempt to present basic scientific considerations for the broadest range of oligonucleotide APIs. Tests and analytical methods suitable for the control of single- and double-stranded oligonucleotide APIs and conjugated oligonucleotide APIs are discussed.\",\"PeriodicalId\":391574,\"journal\":{\"name\":\"Drug information journal : DIJ / Drug Information Association\",\"volume\":\"60 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-05-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"24\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug information journal : DIJ / Drug Information Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/0092861512445311\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug information journal : DIJ / Drug Information Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/0092861512445311","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Quality Aspects of Oligonucleotide Drug Development: Specifications for Active Pharmaceutical Ingredients
This article, which is the first in a planned series intended to address chemistry, manufacturing, and control (CMC) aspects of therapeutic oligonucleotides, examines the topic of specifications for active pharmaceutical ingredients (APIs). The authors attempt to present basic scientific considerations for the broadest range of oligonucleotide APIs. Tests and analytical methods suitable for the control of single- and double-stranded oligonucleotide APIs and conjugated oligonucleotide APIs are discussed.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
